Illumina
Trade Illumina 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ILMN
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions.
ILMN Key Statistics
Stock Snapshot
The current Illumina(ILMN) stock price is $123.39, with a market capitalization of 18.85B. The stock trades at a price-to-earnings (P/E) ratio of 26.18.
During the trading session on 2025-11-05, Illumina(ILMN) shares reached a daily high of $126.00 and a low of $117.33. At a current price of $123.39, the stock is +5.2% higher than the low and still -2.1% under the high.
Trading volume for Illumina(ILMN) stock has reached 1.54M, versus its average volume of 2.27M.
The stock's 52-week range extends from a low of $68.70 to a high of $156.66.
The stock's 52-week range extends from a low of $68.70 to a high of $156.66.
ILMN News
Biotech investors finally got a dose of good news this week. Illumina Inc (NASDAQ:ILMN) staged a powerful comeback, with the stock surging over 23% on Friday af...
In October 2025, Illumina announced higher full-year 2025 earnings guidance, projecting revenue between US$4.27 billion and US$4.31 billion, alongside its third...
Illumina (ILMN) returned to profitability in the past year following a stretch of losses. However, its average annual earnings declined by 18.9% over the last f...
Analyst ratings
48%
of 23 ratingsMore ILMN News
Illumina (ILMN) is up 22.4%, or $22.21 to $121.22. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing t...
Illumina Inc. (NASDAQ:ILMN) stock is trading higher after the company reported better-than-expected third-quarter earnings. ILMN shares are climbing with convi...
Barclays analyst Luke Sergott raised the firm’s price target on Illumina (ILMN) to $100 from $95 and keeps an Underweight rating on the shares following the ear...
Illumina ( (ILMN) ) has released its Q3 earnings. Here is a breakdown of the information Illumina presented to its investors. Elevate Your Investing Strategy:...
Analyst Daniel Brennan of TD Cowen reiterated a Hold rating on Illumina, boosting the price target to $115.00. Elevate Your Investing Strategy: Take advantage o...
Earnings Call Insights Illumina outlines path to high single-digit revenue growth and 20% margins by 2027 amid NovaSeq X acceleration Oct. 30, 2025 10:27 PM ET...
Illumina (ILMN) shares rose post market after the company beat third quarter revenue and profit expectations, while also raising its full year adjust profit tar...
